The FDA has approved Amneal Pharmaceuticals’ ( NASDAQ: AMRX) OTC Naloxone HCl nasal spray, a generic version of the opioid ...
By Chris Wack Amneal Pharmaceuticals shares were up 9% after the Food and Drug Administration approved an abbreviated new drug application ...
The nasal spray product delivers 10mg of naloxone hydrochloride in a single dose. The Food and Drug Administration (FDA) has approved Rezenopy (naloxone hydrochloride) nasal spray for the emergency ...
(RTTNews) - Amneal Pharmaceuticals, Inc. (AMRX) announced on Wednesday that it has received FDA approval for its Over the Counter Naloxone Hydrochloride or HCI Nasal Spray, USP, 4mg. This nasal spray ...
With the FDA nod, Alecensa becomes the second molecularly targeted therapy to move into the adjuvant setting for non-small cell lung cancer.